Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T28025 | Target Info | |||
Target Name | Proto-oncogene c-Fos (c-Fos) | ||||
Synonyms | G0S7; G0/G1 switch regulatory protein 7; Cellular oncogene fos; C-fos | ||||
Target Type | Literature-reported Target | ||||
Gene Name | FOS | ||||
Biochemical Class | Basic leucine zipper bZIP | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Acyltransferases | [+] 2 Acyltransferases | + | |||
Interacting Protein Name | Cyclic AMP-dependent transcription factor ATF-2 (ATF2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CRE.BP1; CREB.2; CREB2; HB16; TREB7 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-MS | [3] | |||
4 | Fluorescence Resonance Energy Transfer | [4] | |||
5 | Reconstituted Complex | [5] | |||
Interacting Protein Name | Nuclear receptor coactivator 1 (NCOA1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | F.SRC.1; KAT13A; RIP160; SRC1; bHLHe42; bHLHe74 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [6] | |||
2 | Reconstituted Complex | [7] | |||
3 | Reconstituted Complex | [6] | |||
4 | Yeast two hybrid | [7] | |||
Transcription regulators | [+] 7 Transcription regulators | + | |||
Interacting Target Name | Transcription factor AP-1 (JUN) | Discontinued Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | V-jun avian sarcoma virus 17 oncogene homolog; Transcription factor AP-1; Proto-oncogene c-jun; P39; C-jun proto-oncogene; AP-1 transcription factor; AP1; Activator protein-1; Activator protein 1 | ||||
Evidence Score (E-score) | 20 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-MS | [8] | |||
4 | Affinity Capture-MS | [3] | |||
5 | Affinity Capture-Western | [9] | |||
6 | Affinity Capture-Western | [10] | |||
7 | Affinity Capture-Western | [11] | |||
8 | Affinity Capture-Western | [12] | |||
9 | Co-fractionation | [12] | |||
10 | Co-localization | [13] | |||
11 | Co-localization | [12] | |||
12 | Fluorescence Resonance Energy Transfer | [10] | |||
13 | Reconstituted Complex | [14] | |||
14 | Reconstituted Complex | [5] | |||
15 | Reconstituted Complex | [15] | |||
16 | Reconstituted Complex | [16] | |||
17 | Reconstituted Complex | [17] | |||
18 | Reconstituted Complex | [18] | |||
19 | Reconstituted Complex | [19] | |||
20 | Yeast two hybrid | [20] | |||
Interacting Protein Name | Transcription factor jun-D (JUND) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AP.1 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-MS | [8] | |||
4 | Affinity Capture-MS | [3] | |||
5 | Affinity Capture-Western | [21] | |||
6 | Reconstituted Complex | [5] | |||
Interacting Protein Name | Transcription factor jun-B (JUNB) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | AP.1 | ||||
Evidence Score (E-score) | 6 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-MS | [8] | |||
4 | Affinity Capture-MS | [3] | |||
5 | Fluorescence Resonance Energy Transfer | [4] | |||
6 | Yeast two hybrid | [22] | |||
Interacting Target Name | Runt-related transcription factor 2 (RUNX2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SL3-3 enhancer factor 1 alpha A subunit; SL3/AKV core-binding factor alpha A subunit; Polyomavirus enhancer-binding protein 2 alpha Asubunit; Polyomavirus enhancer-binding protein 2 alpha A subunit; PEBP2-alpha A; PEBP2A; PEA2-alpha A; Osteoblast-specific transcription factor 2; OSF-2; OSF2; Oncogene AML-3; Core-binding factor subunit alpha-1; CBF-alpha-1; CBFA1; AML3; Acute myeloid leukemia 3 protein | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [23] | |||
2 | Reconstituted Complex | [23] | |||
3 | Yeast two hybrid | [24] | |||
Interacting Protein Name | Cyclic AMP-responsive element-binding protein 5 (CREB5) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CRE.BPA | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Yeast two hybrid | [22] | |||
Interacting Target Name | CREB-binding protein (CREBBP) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CREBbinding protein; CBP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [11] | |||
2 | Reconstituted Complex | [25] | |||
Interacting Target Name | Activating transcription factor 4 (ATF-4) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TXREB; Tax-responsive enhancer element-binding protein 67; Taxresponsive enhancer elementbinding protein 67; TaxREB67; DNA-binding protein TAXREB67; DNAbinding protein TAXREB67; Cyclic AMP-responsive element-binding protein 2; Cyclic AMPresponsive elementbinding protein 2; Cyclic AMP-dependent transcription factor ATF-4; Cyclic AMPdependent transcription factor ATF4; CREB-2; CREB2; cAMP-responsive element-binding protein 2; cAMPresponsive elementbinding protein 2; cAMP-dependent transcription factor ATF-4; cAMPdependent transcription factor ATF4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Co-localization | [26] | |||
2 | Fluorescence Resonance Energy Transfer | [4] | |||
Other proteins | [+] 1 Other proteins | + | |||
Interacting Protein Name | Centromere protein O (CENPO) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CENP.O; ICEN.36; MCM21R | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [3] | |||
2 | Yeast two hybrid | [22] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 2 | The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell. 2015 Jul 16;162(2):425-440. | ||||
REF 3 | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. Mol Syst Biol. 2015 Jan 21;11(1):775. | ||||
REF 4 | Networks of bZIP protein-protein interactions diversified over a billion years of evolution. Science. 2013 May 10;340(6133):730-4. | ||||
REF 5 | A comprehensive resource of interacting protein regions for refining human transcription factor networks. PLoS One. 2010 Feb 24;5(2):e9289. | ||||
REF 6 | Dual role of the arginine methyltransferase CARM1 in the regulation of c-Fos target genes. FASEB J. 2008 Sep;22(9):3337-47. | ||||
REF 7 | Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits. J Biol Chem. 1998 Jul 3;273(27):16651-4. | ||||
REF 8 | A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell. 2015 Oct 22;163(3):712-23. | ||||
REF 9 | Helicobacter pylori induces ERK-dependent formation of a phospho-c-Fos c-Jun activator protein-1 complex that causes apoptosis in macrophages. J Biol Chem. 2010 Jun 25;285(26):20343-57. | ||||
REF 10 | The protein interaction landscape of the human CMGC kinase group. Cell Rep. 2013 Apr 25;3(4):1306-20. | ||||
REF 11 | Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation. Mol Cell Biol. 2005 Aug;25(16):6964-79. | ||||
REF 12 | c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics. Mol Cell Biol. 2010 Aug;30(15):3767-78. | ||||
REF 13 | Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide. Cancer Res. 2012 Aug 15;72(16):4214-24. | ||||
REF 14 | Identification of SWI.SNF complex subunit BAF60a as a determinant of the transactivation potential of Fos/Jun dimers. J Biol Chem. 2001 Jan 26;276(4):2852-7. | ||||
REF 15 | Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogene. 1998 Dec 17;17(24):3145-56. | ||||
REF 16 | Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2. J Biol Chem. 2005 Sep 23;280(38):32569-77. | ||||
REF 17 | Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells. Mol Cancer Ther. 2006 Aug;5(8):2034-42. | ||||
REF 18 | Characterization of a c-Jun-responsive module in the 5'-flank of the human CYP2J2 gene that regulates transactivation. Biochem J. 2005 Nov 1;391(Pt 3):631-40. | ||||
REF 19 | Thioredoxin-1 and its natural inhibitor, vitamin D3 up-regulated protein 1, are differentially regulated by PPARalpha in human macrophages. J Mol Biol. 2008 Dec 19;384(3):564-76. | ||||
REF 20 | Cross-family interaction between the bHLHZip USF and bZip Fra1 proteins results in down-regulation of AP1 activity. Oncogene. 1997 May 1;14(17):2091-8. | ||||
REF 21 | Ten ERK-related proteins in three distinct classes associate with AP-1 proteins and/or AP-1 DNA. J Biol Chem. 2001 Aug 24;276(34):32362-72. | ||||
REF 22 | A proteome-scale map of the human interactome network. Cell. 2014 Nov 20;159(5):1212-1226. | ||||
REF 23 | AP-1 and Cbfa/runt physically interact and regulate parathyroid hormone-dependent MMP13 expression in osteoblasts through a new osteoblast-specific element 2/AP-1 composite element. J Biol Chem. 2001 Jun 8;276(23):20029-38. | ||||
REF 24 | Physical interaction of the activator protein-1 factors c-Fos and c-Jun with Cbfa1 for collagenase-3 promoter activation. J Biol Chem. 2002 Jan 4;277(1):816-22. | ||||
REF 25 | p300 Modulates the BRCA1 inhibition of estrogen receptor activity. Cancer Res. 2002 Jan 1;62(1):141-51. | ||||
REF 26 | Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network. J Proteome Res. 2014 Dec 5;13(12):5339-46. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.